Current status: 1117 hESC lines, 7471 hiPSC lines, and 182 clinical studies, and 2401 certificates
Monthly statistic from Nov 1, 2025
Posted on November 1, 2025
| total lines | 8588 |
| hESC lines | 1117 |
| hiPSC lines | 7471 |
| derivation countries | 52 |
| projects | 332 |
| providers | 1020 |
| clinical studies | 182 |
| subclones | 3824 |
| certificates | 2401 |
| cell line certificates | 2246 |
| project certificates | 155 |